EUVIMEDEUVIMED entdecken
Crossref

Clinical features and prognosis of anti-MDA5-positive dermatomyositis with coexistent anti-aminoacyl-tRNA synthetase antibodies

Gang Wang, Dong Yan, Chenghua Weng, Leixi Xue, Zhichun Liu

Clinical Rheumatology · 2025-02 · 44 (2) · 767-774

DOI: 10.1007/s10067-024-07298-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 03.01.2025. Verfasst von Gang Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Dermatomyositis, Interferon-Induced Helicase, IFIH1, Amino Acyl-tRNA Synthetases, Autoantibodies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Pre-research Fund of the Second Affiliated Hospital of Soochow University, Suzhou Medical Health Science and Technology Innovation Project, Suzhou Health and Key Talent Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to evaluate the incidence and clinical significance of coexistence of anti-aminoacyl-tRNA synthetase (anti-ARS) antibody in patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis (anti-MDA5 + DM). METHODS: We assessed a cohort of 246 consecutive patients with anti-MDA5 + DM. Clinical characteristics and survival rates were compared between patients with and without anti-ARS antibodies. RESULTS: Of these 246 patients, 15 (15/246, 6.1%) were positive for anti-ARS antibodies. The anti-ARS-positive group had a higher proportion of mechanic's hands (53.3% vs 25.5%, P = 0.019), and the positivity rates for antinuclear antibody (ANA) (80.0% vs 50.6%, P = 0.033) and anti-Ro52 antibodies (93.3% vs 62.3%, P = 0.013) were also higher. However, the CRP levels were comparatively low [4.0 (0.5, 7.8) vs 6.0 (3.1, 12.2), P = 0.019]. In the overall population, no difference in survival rates was observed between anti-MDA5 + DM patients with or without anti-ARS antibodies (log-rank P = 0.339). The multivariate Cox regression analysis revealed that elevated lactate dehydrogenase (LDH) levels and the presence of rapidly progressive interstitial lung disease (RPILD) were associated with poor prognosis [hazard ratios of 1.002 (95% CI 1.001, 1.002, P < 0.001) and 11.096 (95% CI 5.006, 24.598, P < 0.001), respectively]. CONCLUSION: Among the 246 patients with anti-MDA5 + DM, only 15 patients (6.1%) tested positive for anti-ARS antibodies. The presence of anti-ARS antibodies is associated with the occurrence of mechanic's hands, as well as an increased positive rate of ANA and anti-Ro52 antibodies. Elevated LDH levels and the presence of RPILD are poor prognostic risk factors for patients with anti-MDA5 + DM. Key Points • The presence of anti-ARS antibodies is associated with the occurrence of mechanic's hands, as well as an increased positive rate of ANA and anti-Ro52 antibodies. • Elevated LDH levels and the presence of RPILD are poor prognostic risk factors for patients with anti-MDA5 + DM. • Understanding the clinical characteristics of these patients will help clinicians to develop individualised treatment plans for each patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatomyositisInterferon-Induced Helicase, IFIH1Amino Acyl-tRNA SynthetasesAutoantibodiesHumansMaleFemaleMiddle AgedPrognosisAgedAdultAntibodies, AntinuclearRetrospective StudiesSurvival RateLung Diseases, Interstitial

Stichwörter der Autor:innen

Anti-Aminoacyl- tRNA synthetaseAnti-MDA5 Positive dermatomyositisAnti-MDA5 antibodyDermatomyositisPrognosisRapidly progressive interstitial lung disease

Substanzen

Interferon-Induced Helicase, IFIH1IFIH1 protein, humanAmino Acyl-tRNA SynthetasesAutoantibodiesAntibodies, Antinuclear

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. zcliurheu@suda.edu.cn.

Förderung

  • Pre-research Fund of the Second Affiliated Hospital of Soochow University
  • Suzhou Medical Health Science and Technology Innovation Project
  • Suzhou Health and Key Talent Project
  • Jiangsu Provincial Health Key Research and Development Project

Zitieren

APA

Wang, G., Yan, D., Weng, C., Xue, L., & Liu, Z. (2025). Clinical features and prognosis of anti-MDA5-positive dermatomyositis with coexistent anti-aminoacyl-tRNA synthetase antibodies. Clinical Rheumatology, 44(2), 767-774. https://doi.org/10.1007/s10067-024-07298-4

Vancouver

Wang G, Yan D, Weng C, Xue L, Liu Z. Clinical features and prognosis of anti-MDA5-positive dermatomyositis with coexistent anti-aminoacyl-tRNA synthetase antibodies. Clinical Rheumatology. 2025;44(2):767-774. doi:10.1007/s10067-024-07298-4

BibTeX
@article{Wang2025,
  author = {Wang, Gang and Yan, Dong and Weng, Chenghua and Xue, Leixi and Liu, Zhichun},
  title = {Clinical features and prognosis of anti-MDA5-positive dermatomyositis with coexistent anti-aminoacyl-tRNA synthetase antibodies},
  journal = {Clinical Rheumatology},
  year = {2025},
  volume = {44},
  number = {2},
  pages = {767--774},
  doi = {10.1007/s10067-024-07298-4}
}
Kostenlos starten →